Data as of Jan 26
| +0.09 / +0.23%|
The 6 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 39.00, with a high estimate of 45.00 and a low estimate of 31.00. The median estimate represents a -1.44% decrease from the last price of 39.57.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.